(Q36654466)

15 August 2017

1 reference

title

Cellular immune responses to hepatitis B virus antigens in man (English)

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

5 November 2022

1 reference

S. P. Sylvan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1710754

5 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1710754

5 November 2022

publication date

1 February 1991

1 reference

full work available at URL

15 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-0676.1991.tb00485.x

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0676.1991.tb00485.x/fullpdf

5 November 2022

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

5 November 2022

1 reference

15 August 2017

volume

11

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

1-23

1 reference

Australia antigen and antibody in 10,000 Danish blood-donors.

15 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Liver disease in Australia-antigen-positive blood-donors.

5 November 2022

2

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

A Study of Australia-Antigen-Positive Blood Donors and Their Recipients, with Special Reference to Liver Histology

5 November 2022

3

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Transmission of Type B Viral Hepatitis to Chimpanzees

5 November 2022

4

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

HBsAg carrier infants with serum anti-HBc negativity

5 November 2022

5

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Cellular immunity and hepatitis-associated, Australia antigen liver disease

5 November 2022

6

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Relation between Australia antigen and autoimmune hepatitis

5 November 2022

7

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Thymus-dependent lymphocyte function in patients with hepatitis-associated antigen

5 November 2022

8

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Lymphocyte transformation and persistent Australia antigen.

5 November 2022

9

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Cellular immunity and hepatitis-associated-antigen liver disease

5 November 2022

10

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Inhibitory effect of Australia-positive sera on in-vitro-stimulated T lymphocytes

5 November 2022

12

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Letter: Persistence of Au-SH antigen and lymphocyte transformation

5 November 2022

13

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Tolerance to hepatitis B antigen: a hypothesis for its termination with 'immune-RNA'.

5 November 2022

14

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Differential distribution of Australia-antigen-associated particles in patients with liver diseases and normal carriers

5 November 2022

15

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Detection of hepatitis B virus DNA in liver and serum: a direct appraisal of the chronic carrier state

5 November 2022

16

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Hepatitis B viral DNA in liver and serum of asymptomatic carriers.

5 November 2022

17

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

A new antigen-antibody system. Clinical significance in long-term carriers of hepatitis B surface antigen

5 November 2022

18

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Dane Particles, DNA Polymerase, and e-Antigen in Two Different Categories of Hepatitis B Antigen Carriers

5 November 2022

19

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Cell-mediated immune response to hepatitis B antigen in patients with liver disease.

5 November 2022

20

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Exposure and immunity to hepatitis-B virus in a liver unit

5 November 2022

21

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Cell-mediated immune response to liver tissue antigen and hepatitis B surface antigen after infection with hepatitis B virus in humans

5 November 2022

22

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Specific lymphocyte stimulation by purified, heat-inactivated hepatitis-B antigen.

5 November 2022

23

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Role of interferon in recovery from virus infections

5 November 2022

24

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

CIRCULATING VIRUS, INTERFERON AND ANTIBODY AFTER VACCINATION WITH THE 17-D STRAIN OF YELLOW-FEVER VIRUS.

5 November 2022

26

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

CIRCULATING INTERFERON AFTER MEASLES VACCINATION

5 November 2022

27

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Absence of circulating interferon in patients with infectious and serum hepatitis

5 November 2022

29

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Failure to Demonstrate Circulating Interferon During Incubation Period and Acute Stage of Transfusion-Associated Hepatitis

5 November 2022

30

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Absence of detectable serum interferon in acute and chronic viral hepatitis

5 November 2022

31

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Interferon system in acute viral hepatitis

5 November 2022

32

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Natural killer activity in patients with acute viral hepatitis

5 November 2022

33

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Interferon deficiency syndrome

5 November 2022

35

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Interferons and the immune system

5 November 2022

37

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

5 November 2022

INTERFERONS

38

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Assay of an interferon-induced enzyme in white blood cells as a diagnostic aid in viral diseases

5 November 2022

39

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Lack of in vivo activation of the interferon system in HBsAg-positive chronic active hepatitis

5 November 2022

41

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Interferon-associated lymphocyte 2',5'-oligoadenylate synthetase in acute and chronic viral hepatitis

5 November 2022

42

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Elevated levels of 2',5'-oligoadenylate synthetase activity in peripheral blood mononuclear cells and serum during acute exacerbation of chronic hepatitis B

5 November 2022

43

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Relationship of HLA protein display to activation of 2-5A synthetase in HBe antigen or anti-HBe positive chronic HBV infection

5 November 2022

44

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Cellular localization of alpha-interferon in hepatitis B virus-infected liver tissue

5 November 2022

45

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Heterogeneity of Human Gamma Interferon Preparations: Evidence for Presence of Alpha Interferon*

5 November 2022

47

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Decreased Interferon Response by Lymphocytes from Children with Chronic Hepatitis

5 November 2022

48

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Normal lymphocyte interferon production in adult HBsAg-positive chronic active liver disease

5 November 2022

49

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Production of interferon alpha and interferon gamma by peripheral blood leukocytes from patients with chronic hepatitis B virus infection

5 November 2022

50

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Lack of correlation between interferon production of mononuclear cells and virus replication in chronic hepatitis B virus infection

5 November 2022

51

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Interferon production by peripheral lymphocytes in HBsAg-positive liver diseases

5 November 2022

52

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Evidence for a deficiency of interferon production in patients with chronic hepatitis B virus infection acquired in adult life

5 November 2022

53

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Interferon-gamma production by peripheral blood mononuclear cells of patients with chronic liver disease

5 November 2022

54

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Interleukin-2, interleukin-2 receptor and gamma-interferon synthesis by peripheral blood mononuclear cells in chronic hepatitis delta virus infection

5 November 2022

55

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Interferon production in patients infected with HIV-1

5 November 2022

56

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Antigen-induced production of lymphokines by human T cell clones specific for hepatitis B surface antigen

5 November 2022

62

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Regulation of T-cell function by antibodies: enhancement of the response of human T-cell clones to hepatitis B surface antigen by antigen-specific monoclonal antibodies

5 November 2022

63

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Immune Specific Induction of Interferon Production in Cultures of Human Blood Lymphocytes

5 November 2022

64

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

The interaction of human macrophages and lymphocytes in the phytohemagglutinin-stimulated production of interferon

5 November 2022

65

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Enhancement of interferon-gamma production in glycyrrhizin-treated human peripheral lymphocytes in response to concanavalin A and to surface antigen of hepatitis B virus

5 November 2022

67

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

5 November 2022

Interleukin 2.

68

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Interleukin 2: the molecule and its function

5 November 2022

70

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Interleukin-2 activity in chronic active liver diseases: response by T cells and in the autologous mixed lymphocyte reaction

5 November 2022

72

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

In vitro alpha-interferon treatment of peripheral blood mononuclear cells improves interleukin-2 activity in HBV-related chronic liver disease

5 November 2022

73

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Interleukin-1 and interleukin-2 activity in chronic hepatitis B virus infection.

5 November 2022

74

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Interleukins in chronic active hepatitis B. Relationship with viral markers.

5 November 2022

75

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Abnormal T-cell activation in chronic hepatitis B viral infection: a consequence of monocyte dysfunction?

5 November 2022

78

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Soluble interleukin 2 receptor in acute viral hepatitis and chronic liver disease

5 November 2022

80

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Increased serum soluble interleukin 2 receptor levels in patients with viral liver diseases

5 November 2022

81

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Serum levels of soluble interleukin-2 receptors in acute and chronic viral hepatitis

5 November 2022

82

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Detection of hepatitis B surface antigen (HBsAg) in peripheral blood mononuclear cells of patients with acute and chronic active hepatitis B

5 November 2022

83

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Viral inhibition of lymphocyte mitogenesis: interference with the synthesis of functionally active T cell growth factor (TCGF) activity and reversal of inhibition by the addition of same

5 November 2022

84

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Phytohaemagglutinin Unresponsiveness of Lymphocytes from Babies with Congenital Rubella

5 November 2022

86

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Viral inhibition of the phytohemagglutinin response of human lymphocytes and application to viral hepatitis

5 November 2022

87

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Studies on the mechanism of measles virus-induced suppression of lymphocyte functions in vitro: lack of a role for interferon and monocytes

5 November 2022

88

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Cell-mediated immunity in acute and chronic hepatitis

5 November 2022

92

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Effect of HBV antigens and their immune complexes on the PHA induced lymphocyte proliferation. Modulatory influence on interleukin-2 activity

5 November 2022

93

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Rubella virus and human lymphocytes in culture

5 November 2022

95

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Lymphocyte blastogenic responses to influenza virus antigens after influenza infection and vaccination in humans

5 November 2022

96

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Cell-mediated Immunity in Patients Positive for Hepatitis-associated Antigen

5 November 2022

102

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Hepatitis virus B and chronic alcoholic liver disease

5 November 2022

103

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Chronic Hepatitis — Migration Inhibition of Leukocytes in the Presence of Australia Antigen

5 November 2022

104

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

[Cellular immune response to hepatitis-associated antigen and homologous liver-specific protein in acute HAA-positive hepatitis (author's transl)]

5 November 2022

105

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Delayed hypersensitivity in hepatitis B: clinical correlates of in vitro production of migration inhibition factor

5 November 2022

106

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Immune responses to the hepatitis B surface antigen and liver-specific lipoprotein in acute type B hepatitis

5 November 2022

110

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Humoral and cell-mediated immunity to hepatitis B virus antigens in acute and chronic liver disease

5 November 2022

111

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Immune response to hepatitis B surface antigen

5 November 2022

114

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Technical study of the leucocyte migration inhibition test in agarose. Application to PPD and to hepatitis B antigen

5 November 2022

115

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Lack of leukocyte migration inhibition by hepatitis B antigen and normal nonspecific immunoreactivity in asymptomatic carriers

5 November 2022

116

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Cell-mediated immunity in response to HBs antigen

5 November 2022

117

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

T lymphocyte sensitization to HBcAg and T cell-mediated unresponsiveness to HBsAg in hepatitis B virus-related chronic liver disease.

5 November 2022

118

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Prospective study of cellular immunity to hepatitis-B-virus antigens from the early incubation phase of acute hepatitis B.

5 November 2022

119

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Cell-mediated immunity to hepatitis B surface antigen in blood donors with persistent antigenaemia

5 November 2022

120

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Asymptomatic hapatic disease in blood donors with hepatitis B antigenemia

5 November 2022

122

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Development of skin reaction to hepatitis B vaccines in man

5 November 2022

124

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Cell-mediated immunity to hepatitis B surface antigen in man

5 November 2022

125

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Antibody responses and skin reactivity after intradermal hepatitis B virus vaccine

5 November 2022

126

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Development of DTH skin reaction to HBsAg in individuals immunized with HB vaccine

5 November 2022

127

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Delayed-type hypersensitivity to influenza virus. Induction of antigen-specific suppressor T cells for delayed-type hypersensitivity to hemagglutinin during influenza virus infection in mice

5 November 2022

129

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Lymphocyte stimulation in hepatitis B infections

5 November 2022

130

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Evidence for a role of hepatitis virus B in chronic alcoholic liver disease

5 November 2022

132

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Lymphocyte transformation and leucocyte migration-inhibition by Australia antigen

5 November 2022

133

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

T-cell subsets in the hyporesponsiveness to hepatitis B surface antigen (HBsAg) and antigen-specific suppressor lymphocytes in chronic hepatitis B virus (HBV) infection

5 November 2022

134

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Cellular immunity to the hepatitis B virion in acute hepatitis type B

5 November 2022

135

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

In vitro response to HBsAg of peripheral blood lymphocytes from recipients of hepatitis B vaccine

5 November 2022

136

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

HBsAg-Serum Protein Complexes Stimulate Immune T Lymphocytes More Efficiently Than Do Pure HBsAg

5 November 2022

141

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Regulation of the human immune response to HBsAg: effects of antibodies and antigen conformation in the stimulation of helper T cells by HBsAg

5 November 2022

142

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Absence of pre-S2 antibodies in natural hepatitis B virus infection

5 November 2022

143

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Human T cell response to the surface antigen of hepatitis B virus (HBsAg). Endosomal and nonendosomal processing pathways are accessible to both endogenous and exogenous antigen

5 November 2022

144

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

The preS1 antigen of hepatitis B virus is highly immunogenic at the T cell level in man.

5 November 2022

145

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Hepatitis B surface antigen-specific cell-mediated immune responses in human chronic hepatitis B surface antigen carriers

5 November 2022

149

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

The role of the macrophage in in vitro primary anti-DNP antibody production in man

5 November 2022

150

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

The glycoprotein isolated from vesicular stomatitis virus is mitogenic for mouse B lymphocytes

5 November 2022

153

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Mitogenic activity of Sindbis virus and its isolated glycoproteins.

5 November 2022

154

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Protection against hepatitis B virus infection by immunization with hepatitis B core antigen

5 November 2022

155

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Protective immunisation against hepatitis B with an internal antigen of the virus

5 November 2022

156

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

The conversion of hepatitis B core antigen synthesized in E coli into e antigen

5 November 2022

157

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Viral hepatitis, type B. Studies on natural history and prevention re-examined

5 November 2022

158

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Intrahepatic, nucleocapsid antigen-specific T cells in chronic active hepatitis B

5 November 2022

162

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Functional modulation of hepatitis B core antigen-specific T lymphocytes by an autoreactive T cell clone

5 November 2022

163

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Serologic markers of hepatitis B virus infection

5 November 2022

164

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg Vs. anti-HBe positive carriers of hepatitis B virus

5 November 2022

166

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

In vitro antigen-induced, antigen-specific antibody production in man. Specific and polyclonal components, kinetics, and cellular requirements

5 November 2022

167

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

In vitro antigen-induced antibody responses to hepatitis B surface antigen in man. Kinetic and cellular requirements

5 November 2022

168

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

In vitro immune responses to hepatitis B surface antigen (Pre-S2 and S) following remote infection by hepatitis B virus in humans

5 November 2022

171

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients

5 November 2022

172

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Induction of the in vitro anti-HBs response by hepatitis B surface antigen

5 November 2022

173

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Complexes of hepatitis B surface antigen and immunoglobulin M in the sera of patients with hepatitis B virus infection

5 November 2022

177

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Immunological aspects of cryoprecipitates from the sera of chronic HBsAg carriers

5 November 2022

179

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane

5 November 2022

181

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Glomerulonephritis associated with hepatitis-B surface antigen immune complexes in children

5 November 2022

182

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Frequency and significance of concurrent hepatitis B surface antigen and antibody in acute and chronic hepatitis B.

5 November 2022

183

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Anti-HBs- and anti-HBc-containing plasma cells in livers of patients with chronic type B hepatitis

5 November 2022

184

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers

5 November 2022

185

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Impaired antibody synthesis in patients with chronic hepatitis B infection

5 November 2022

187

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Depression of cell-mediated immunity during acute infectious mononucleosis

5 November 2022

188

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Abnormalities of in vitro lymphocyte responses during rubella virus infections

5 November 2022

190

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Suppression of leukocytic mitosis by sera of hepatitis-implicated donors.

5 November 2022

193

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Neonatal onset of the hepatitis-associated-antigen carrier state.

5 November 2022

195

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Exposure to hepatitis B virus and development of the chronic HBAg carrier state in children

5 November 2022

196

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Chronic hepatitis B in male and female children of HBsAg carrier mothers

5 November 2022

197

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Horizontal transmission of hepatitis B virus

5 November 2022

198

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire

5 November 2022

200

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Characterisation of the polymerised and monomeric human serum albumin binding sites on hepatitis B surface antigen

5 November 2022

202

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Human hepatitis B vaccine from recombinant yeast

5 November 2022

208

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Clinical evaluation of a recombinant hepatitis B vaccine

5 November 2022

209

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Human B lymphocyte function: cell triggering and immunoregulation

5 November 2022

210

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

The isolation and characterization of the human helper inducer T cell subset

5 November 2022

211

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Suppression of hepatitis B antibody synthesis by factor made by T cells from chronic hepatitis B carriers

5 November 2022

212

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Serum inhibitory factors (SIF) are of prognostic value in acute viral hepatitis

5 November 2022

213

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

CD8+ T lymphocytes in intracellular microbial infections

5 November 2022

214

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Pathways of viral antigen processing and presentation to CTL: defined by the mode of virus entry?

5 November 2022

215

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Serum markers of hepatitis B virus replication, liver histology and intrahepatic expression of hepatitis B core antigen

5 November 2022

217

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Correlation of hepatocyte HBsAg expression with virus replication and liver pathology

5 November 2022

218

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

HBsAg and HBcAg in the livers of asymptomatic hepatitis B antigen carriers

5 November 2022

219

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Intrahepatic distribution of hepatitis B surface and core antigens in chronic hepatitis B virus infection. Hepatocyte with cytoplasmic/membranous hepatitis B core antigen as a possible target for immune hepatocytolysis.

5 November 2022

220

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes

5 November 2022

221

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Recognition of influenza A virus nucleoprotein by human cytotoxic T lymphocytes

5 November 2022

222

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Recognition of cloned vesicular stomatitis virus internal and external gene products by cytotoxic T lymphocytes

5 November 2022

224

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Vaccinia recombinant expressing Lassa-virus internal nucleocapsid protein protects guineapigs against Lassa fever

5 November 2022

225

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Nucleotide sequence of the G protein gene of human respiratory syncytial virus reveals an unusual type of viral membrane protein

5 November 2022

228

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Antibodies to respiratory syncytial virus polypeptides and their significance in human infection

5 November 2022

229

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

HLA antigens in patients with various courses after hepatitis B virus infection

5 November 2022

231

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Current concepts in immunology: Regulation of the immune response--inducer and suppressor T-lymphocyte subsets in human beings

5 November 2022

233

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

The isolation and characterization of the human helper inducer T cell subset

5 November 2022

234

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

The isolation and characterization of the human suppressor inducer T cell subset

5 November 2022

235

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Epitope-Specific Regulation

5 November 2022

236

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Isolation of antigen-specific T cell clones from nonresponder mice

5 November 2022

237

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

A solid-phase enzyme immunoassay for the determination of IgM and IgG antibodies against translation products of pre-S1 and pre-S2 regions of hepatitis B virus

5 November 2022

238

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Significance of pre-S2 peptide of hepatitis B virus: should it be in the vaccine?

5 November 2022

240

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Dissociated antibody responses to the S and pre-S2 regions of the hepatitis B virus after vaccination in hemophiliacs

5 November 2022

241

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Immunoglobulin G subclass restriction of antibodies against hepatitis B surface antigen

5 November 2022

243

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Proportions of IgG subclasses in antibodies formed during vaccination with hepatitis B surface antigen

5 November 2022

244

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

The use of human antigen-specific monoclonal antibodies in an enzyme-linked immunosorbent assay for the determination of anti-HBsAg antibody subclasses.

5 November 2022

245

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Inhibition of the immune response by Fc receptor-bound specific antibody on T lymphocytes

5 November 2022

247

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Detection of an IgM antiidiotype directed against anti-HBs in hepatitis B patients

5 November 2022

249

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

IgG and IgM autoantiidiotype antibodies against antibody to HBsAg in chronic hepatitis B

5 November 2022

250

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Genetic prediction of nonresponse to hepatitis B vaccine

5 November 2022

253

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

Human serum albumin and the enigma of chronic hepatitis type B.

5 November 2022

255

1 reference

https://api.crossref.org/works/10.1111/J.1600-0676.1991.TB00485.X

5 November 2022

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1710754

5 November 2022

1 reference